La cabergolina se sugiere actualmente en lugar de bromocriptina, debido a su del período menstrual debe suspenderse el fármaco y confirmar el embarazo. Publisher: Cabergolina y bromocriptina son los fármacos más utilizados probablemente aumenta la probabilidad de embarazo, y se asocia a. El uso de cabergolina no afecta el resultado de embarazo (tasa de embarazo clínico, tasa de aborto espontáneo), ni existe un aumento en el riesgo de eventos .
|Published (Last):||2 December 2005|
|PDF File Size:||8.50 Mb|
|ePub File Size:||7.88 Mb|
|Price:||Free* [*Free Regsitration Required]|
A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea.
Cabergolinna prolactinomas are the most common functioning pituitary tumors. The hyperprolactinemia is associated with anovulation and infertility. Indian J Med Res. Cabergolina versus bromocriptina para la hiperprolactinemia o prolactinoma.
J Clin Endocrinol Metab. Osteocalcin levels in patients with microprolactinoma before and during medical treatment. Cabergoline currently suggested rather than bromocriptine due to their excellent tolerability and long half-life. Comparison of the effects of cabergoline and bromocriptine in women with hyperprolactinemic amenorrhea.
Primary medical therapy of micro- and macroprolactinomas in men. Comparative effects of bromocriptine and cabergoline on serum prolactin levels, liver and kidney function tests in hyperprolactinemic women.
Medwave se preocupa por su privacidad y la seguridad de sus datos personales. Comparison of cabergoline and bromocriptine in patients with asymptomatic incidental hyperprolactinemia undergoing ICSI-ET. In microprolactinomas the ophthalmologic examination is no formal indication. Cabergoline is a long-acting dopamine receptor agonist which might offer advantages over bromocriptine.
Pakistan Journal of Medical Sciences Online. There is evidence that breastfeeding no increased risk for tumor growth. In the eembarazo of menstrual period, the drug should be discontinued and confirm pregnancy. In general, it is recommended that fetal exposure to all drugs be limited to as short a period as possible.
Sobre los desenlaces incluidos en este resumen. Cabergoline and bromocriptine are among the most commonly used drugs to treat prolactinoma. Cabergoline or bromocriptine for prolactinoma?.
Para un estudio no se especifican dosis de cabergolina cabeegolina bromocriptina en ninguna de las revisiones identificadas . N Engl J Med. Middle East Fertility Society Journal.
Su principal desarrollo es la base de datos Epistemonikos www. Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: However, it is not clear if this translates into clinical benefits.
Searching in Epistemonikos database, which is maintained by screening 30 databases, we identified two systematic reviews including 12 studies addressing the question of this article, including five randomized controlled trials. It is not clear whether cabergoline is also more effective with respect to tumor growth because the certainty of the evidence is very low.
Diagnosis and treatment of yperprolactinemia: Todos los estudios compararon bromocriptina versus cabergolina. The patients with macroprolactinomas should be monitored clinically and evaluate the symptoms related to increased tumor size. Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients.
Cabergoline Comparative Study Group. La bromocriptina se asocia a mayores efectos adversos que cabergolina. Hay evidencia de que la lactancia materna no presenta mayor riesgo para el crecimiento tumoral.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.